AEYE Health

Company Overview

Snapshot

Founded in June 2018 by Zack Dvey-Aharon and Danny Margalit, AEYE Health operates with 11–50 employees. The company has raised $10 million across three funding rounds from six investors. In November 2022, AEYE Health received FDA clearance for its AI-based autonomous screening for referable diabetic retinopathy.

Business overview

AEYE Health is a venture-backed digital health startup that develops AI algorithms for the immediate and autonomous interpretation of fundus images. Its core technology enables point-of-care retinal screenings to help primary care physicians detect various conditions and prevent avoidable vision loss. The company operates within the Health Tech & Life Sciences sector, specifically focusing on digital medical diagnostics, and serves the healthcare industry.

Strategic signal

In April 2024, AEYE Health received FDA clearance for the first fully autonomous AI designed for portable diabetic retinopathy screening. This milestone signifies a critical validation of the company's technology and its potential to expand access to early detection of diabetic retinopathy, positioning AEYE Health as a leader in AI-driven ophthalmic diagnostics and enhancing its market penetration in primary care settings.

Company Intelligence Q&A

What significant regulatory milestone did AEYE Health achieve recently?

In April 2024, AEYE Health received FDA clearance for the first fully autonomous AI for portable diabetic retinopathy screening, expanding the accessibility of its diagnostic technology.

When did AEYE Health receive FDA clearance for its AI-based autonomous screening for diabetic retinopathy?

AEYE Health received FDA clearance for its AI-based autonomous screening for referable diabetic retinopathy in November 2022.

What was a key partnership announced by AEYE Health in 2023?

In July 2023, IRIS and AEYE Health announced a partnership to provide AI screening to the market, aiming to broaden the reach of AEYE Health's diagnostic solutions.

What research results did AEYE Health announce in January 2023?

In January 2023, AEYE Health announced best-in-class results proving its AI software is capable of predicting the future development of diabetic retinopathy in patients before diagnosable symptoms manifest.

Which institution is researching the use of AEYE Health's AI-based retinal camera screenings?

UMass Chan Medical School and AEYE Health are researching the use of AI-based retinal camera screenings in primary care practice, as reported in February 2023.